| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ASAH1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | GCLM | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | QPCT | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | UGDH | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GLRX2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GJB1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | TGIF2-C20orf24 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | NFATC4 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PRDM7 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | CPN1 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
